nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Progesterone—uterine cancer	0.108	0.393	CbGbCtD
Scopolamine—ABCB1—Dactinomycin—uterine cancer	0.0853	0.311	CbGbCtD
Scopolamine—CHRM3—ureter—uterine cancer	0.0618	0.327	CbGeAlD
Scopolamine—Acute psychosis—Medroxyprogesterone Acetate—uterine cancer	0.0493	0.0918	CcSEcCtD
Scopolamine—ABCB1—Etoposide—uterine cancer	0.0482	0.176	CbGbCtD
Scopolamine—CHRM3—muscle of abdomen—uterine cancer	0.0445	0.235	CbGeAlD
Scopolamine—ABCB1—Doxorubicin—uterine cancer	0.0328	0.12	CbGbCtD
Scopolamine—SI—female reproductive system—uterine cancer	0.0182	0.0963	CbGeAlD
Scopolamine—Rash generalised—Progesterone—uterine cancer	0.0173	0.0323	CcSEcCtD
Scopolamine—Rash generalised—Medroxyprogesterone Acetate—uterine cancer	0.0157	0.0292	CcSEcCtD
Scopolamine—CHRM3—exocrine gland—uterine cancer	0.0122	0.0643	CbGeAlD
Scopolamine—Redness—Progesterone—uterine cancer	0.0109	0.0203	CcSEcCtD
Scopolamine—Paranoia—Medroxyprogesterone Acetate—uterine cancer	0.00978	0.0182	CcSEcCtD
Scopolamine—CHRM5—epithelium—uterine cancer	0.00947	0.0501	CbGeAlD
Scopolamine—Speech disorder—Progesterone—uterine cancer	0.00856	0.0159	CcSEcCtD
Scopolamine—Disturbance in attention—Progesterone—uterine cancer	0.0085	0.0158	CcSEcCtD
Scopolamine—Speech disorder—Medroxyprogesterone Acetate—uterine cancer	0.00775	0.0144	CcSEcCtD
Scopolamine—Depressed level of consciousness—Progesterone—uterine cancer	0.00711	0.0132	CcSEcCtD
Scopolamine—Disorientation—Progesterone—uterine cancer	0.00597	0.0111	CcSEcCtD
Scopolamine—Thirst—Progesterone—uterine cancer	0.00561	0.0105	CcSEcCtD
Scopolamine—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00515	0.0096	CcSEcCtD
Scopolamine—CHRM3—smooth muscle tissue—uterine cancer	0.0051	0.027	CbGeAlD
Scopolamine—Irritability—Progesterone—uterine cancer	0.0051	0.0095	CcSEcCtD
Scopolamine—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00509	0.00948	CcSEcCtD
Scopolamine—CHRM3—renal system—uterine cancer	0.00491	0.026	CbGeAlD
Scopolamine—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00473	0.00881	CcSEcCtD
Scopolamine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00462	0.00861	CcSEcCtD
Scopolamine—Dysphagia—Progesterone—uterine cancer	0.00462	0.0086	CcSEcCtD
Scopolamine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.0046	0.00858	CcSEcCtD
Scopolamine—Dry skin—Medroxyprogesterone Acetate—uterine cancer	0.00444	0.00827	CcSEcCtD
Scopolamine—CHRM1—female reproductive system—uterine cancer	0.0044	0.0232	CbGeAlD
Scopolamine—Dysuria—Progesterone—uterine cancer	0.00432	0.00804	CcSEcCtD
Scopolamine—Pain—Carboplatin—uterine cancer	0.00427	0.00796	CcSEcCtD
Scopolamine—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.00795	CcSEcCtD
Scopolamine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00779	CcSEcCtD
Scopolamine—Drowsiness—Progesterone—uterine cancer	0.00412	0.00767	CcSEcCtD
Scopolamine—Conjunctivitis—Progesterone—uterine cancer	0.004	0.00746	CcSEcCtD
Scopolamine—Body temperature increased—Carboplatin—uterine cancer	0.00395	0.00736	CcSEcCtD
Scopolamine—CHRM3—female reproductive system—uterine cancer	0.00393	0.0208	CbGeAlD
Scopolamine—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.00729	CcSEcCtD
Scopolamine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00373	0.00695	CcSEcCtD
Scopolamine—Pharyngitis—Progesterone—uterine cancer	0.00367	0.00683	CcSEcCtD
Scopolamine—Urinary tract disorder—Progesterone—uterine cancer	0.00365	0.0068	CcSEcCtD
Scopolamine—Urethral disorder—Progesterone—uterine cancer	0.00362	0.00675	CcSEcCtD
Scopolamine—CHRM3—female gonad—uterine cancer	0.00358	0.0189	CbGeAlD
Scopolamine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00358	0.00666	CcSEcCtD
Scopolamine—Visual impairment—Progesterone—uterine cancer	0.00356	0.00664	CcSEcCtD
Scopolamine—Eye disorder—Progesterone—uterine cancer	0.00345	0.00643	CcSEcCtD
Scopolamine—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00341	0.00635	CcSEcCtD
Scopolamine—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00619	CcSEcCtD
Scopolamine—Urinary tract disorder—Medroxyprogesterone Acetate—uterine cancer	0.00331	0.00616	CcSEcCtD
Scopolamine—Urethral disorder—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00612	CcSEcCtD
Scopolamine—Dysphagia—Dactinomycin—uterine cancer	0.00326	0.00608	CcSEcCtD
Scopolamine—Mental disorder—Progesterone—uterine cancer	0.00324	0.00603	CcSEcCtD
Scopolamine—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.00601	CcSEcCtD
Scopolamine—Erythema—Progesterone—uterine cancer	0.00322	0.00599	CcSEcCtD
Scopolamine—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.00583	CcSEcCtD
Scopolamine—Redness—Epirubicin—uterine cancer	0.00313	0.00582	CcSEcCtD
Scopolamine—Vision blurred—Progesterone—uterine cancer	0.00303	0.00565	CcSEcCtD
Scopolamine—Tremor—Progesterone—uterine cancer	0.00301	0.00562	CcSEcCtD
Scopolamine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00293	0.00547	CcSEcCtD
Scopolamine—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00292	0.00543	CcSEcCtD
Scopolamine—Redness—Doxorubicin—uterine cancer	0.00289	0.00539	CcSEcCtD
Scopolamine—Vertigo—Progesterone—uterine cancer	0.00289	0.00539	CcSEcCtD
Scopolamine—Amblyopia—Epirubicin—uterine cancer	0.00273	0.00509	CcSEcCtD
Scopolamine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00509	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00272	0.00507	CcSEcCtD
Scopolamine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00499	CcSEcCtD
Scopolamine—Dry mouth—Progesterone—uterine cancer	0.00268	0.00499	CcSEcCtD
Scopolamine—Confusional state—Progesterone—uterine cancer	0.00265	0.00493	CcSEcCtD
Scopolamine—Oedema—Progesterone—uterine cancer	0.00263	0.00489	CcSEcCtD
Scopolamine—ABCB1—myometrium—uterine cancer	0.00262	0.0139	CbGeAlD
Scopolamine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00262	0.00488	CcSEcCtD
Scopolamine—Pharyngitis—Dactinomycin—uterine cancer	0.00259	0.00483	CcSEcCtD
Scopolamine—Nervous system disorder—Progesterone—uterine cancer	0.00258	0.0048	CcSEcCtD
Scopolamine—Tachycardia—Progesterone—uterine cancer	0.00256	0.00477	CcSEcCtD
Scopolamine—Skin disorder—Progesterone—uterine cancer	0.00255	0.00475	CcSEcCtD
Scopolamine—Hyperhidrosis—Progesterone—uterine cancer	0.00254	0.00473	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—uterine cancer	0.00253	0.00471	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00459	CcSEcCtD
Scopolamine—Hypotension—Progesterone—uterine cancer	0.00245	0.00457	CcSEcCtD
Scopolamine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00243	0.00452	CcSEcCtD
Scopolamine—Flushing—Dactinomycin—uterine cancer	0.00242	0.00452	CcSEcCtD
Scopolamine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00447	CcSEcCtD
Scopolamine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00238	0.00443	CcSEcCtD
Scopolamine—Dysphagia—Etoposide—uterine cancer	0.00236	0.0044	CcSEcCtD
Scopolamine—Somnolence—Progesterone—uterine cancer	0.00233	0.00435	CcSEcCtD
Scopolamine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00233	0.00435	CcSEcCtD
Scopolamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00433	CcSEcCtD
Scopolamine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00231	0.00431	CcSEcCtD
Scopolamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00429	CcSEcCtD
Scopolamine—Erythema—Dactinomycin—uterine cancer	0.00227	0.00424	CcSEcCtD
Scopolamine—Fatigue—Progesterone—uterine cancer	0.00226	0.00422	CcSEcCtD
Scopolamine—Constipation—Progesterone—uterine cancer	0.00225	0.00418	CcSEcCtD
Scopolamine—Pain—Progesterone—uterine cancer	0.00225	0.00418	CcSEcCtD
Scopolamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00414	CcSEcCtD
Scopolamine—Feeling abnormal—Progesterone—uterine cancer	0.00216	0.00403	CcSEcCtD
Scopolamine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00394	CcSEcCtD
Scopolamine—Body temperature increased—Progesterone—uterine cancer	0.00208	0.00387	CcSEcCtD
Scopolamine—Abdominal pain—Progesterone—uterine cancer	0.00208	0.00387	CcSEcCtD
Scopolamine—ABCB1—epithelium—uterine cancer	0.00206	0.0109	CbGeAlD
Scopolamine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00382	CcSEcCtD
Scopolamine—ABCB1—uterine cervix—uterine cancer	0.00204	0.0108	CbGeAlD
Scopolamine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00379	CcSEcCtD
Scopolamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00365	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—uterine cancer	0.00195	0.00363	CcSEcCtD
Scopolamine—ABCB1—decidua—uterine cancer	0.00195	0.0103	CbGeAlD
Scopolamine—ABCB1—renal system—uterine cancer	0.00191	0.0101	CbGeAlD
Scopolamine—Asthenia—Progesterone—uterine cancer	0.00188	0.00351	CcSEcCtD
Scopolamine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.0035	CcSEcCtD
Scopolamine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.0035	CcSEcCtD
Scopolamine—Urinary tract disorder—Etoposide—uterine cancer	0.00187	0.00348	CcSEcCtD
Scopolamine—Pruritus—Progesterone—uterine cancer	0.00186	0.00346	CcSEcCtD
Scopolamine—Oedema—Dactinomycin—uterine cancer	0.00186	0.00346	CcSEcCtD
Scopolamine—Urethral disorder—Etoposide—uterine cancer	0.00185	0.00345	CcSEcCtD
Scopolamine—ABCB1—endometrium—uterine cancer	0.00185	0.00976	CbGeAlD
Scopolamine—Dry eye—Doxorubicin—uterine cancer	0.0018	0.00336	CcSEcCtD
Scopolamine—ABCB1—mammalian vulva—uterine cancer	0.00179	0.00944	CbGeAlD
Scopolamine—Eye disorder—Etoposide—uterine cancer	0.00177	0.00329	CcSEcCtD
Scopolamine—Flushing—Etoposide—uterine cancer	0.00175	0.00327	CcSEcCtD
Scopolamine—Dizziness—Progesterone—uterine cancer	0.00174	0.00323	CcSEcCtD
Scopolamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00318	CcSEcCtD
Scopolamine—Eczema—Epirubicin—uterine cancer	0.0017	0.00318	CcSEcCtD
Scopolamine—ABCB1—uterus—uterine cancer	0.0017	0.009	CbGeAlD
Scopolamine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00314	CcSEcCtD
Scopolamine—Vomiting—Progesterone—uterine cancer	0.00167	0.00311	CcSEcCtD
Scopolamine—Rash—Progesterone—uterine cancer	0.00166	0.00308	CcSEcCtD
Scopolamine—Dermatitis—Progesterone—uterine cancer	0.00165	0.00308	CcSEcCtD
Scopolamine—Headache—Progesterone—uterine cancer	0.00165	0.00306	CcSEcCtD
Scopolamine—Fatigue—Dactinomycin—uterine cancer	0.0016	0.00298	CcSEcCtD
Scopolamine—Pain—Dactinomycin—uterine cancer	0.00159	0.00296	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—uterine cancer	0.00158	0.00294	CcSEcCtD
Scopolamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00293	CcSEcCtD
Scopolamine—Nausea—Progesterone—uterine cancer	0.00156	0.00291	CcSEcCtD
Scopolamine—ABCB1—female reproductive system—uterine cancer	0.00153	0.00809	CbGeAlD
Scopolamine—Feeling abnormal—Dactinomycin—uterine cancer	0.00153	0.00285	CcSEcCtD
Scopolamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00282	CcSEcCtD
Scopolamine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00279	CcSEcCtD
Scopolamine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00279	CcSEcCtD
Scopolamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00278	CcSEcCtD
Scopolamine—Vertigo—Etoposide—uterine cancer	0.00148	0.00275	CcSEcCtD
Scopolamine—Abdominal pain—Dactinomycin—uterine cancer	0.00147	0.00273	CcSEcCtD
Scopolamine—Body temperature increased—Dactinomycin—uterine cancer	0.00147	0.00273	CcSEcCtD
Scopolamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00263	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—uterine cancer	0.0014	0.00262	CcSEcCtD
Scopolamine—ABCB1—female gonad—uterine cancer	0.00139	0.00736	CbGeAlD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00139	0.00259	CcSEcCtD
Scopolamine—ABCB1—vagina—uterine cancer	0.00138	0.00731	CbGeAlD
Scopolamine—Confusional state—Etoposide—uterine cancer	0.00135	0.00252	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—uterine cancer	0.00135	0.00252	CcSEcCtD
Scopolamine—Asthenia—Dactinomycin—uterine cancer	0.00133	0.00248	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—uterine cancer	0.00132	0.00247	CcSEcCtD
Scopolamine—Tachycardia—Etoposide—uterine cancer	0.00131	0.00244	CcSEcCtD
Scopolamine—Skin disorder—Etoposide—uterine cancer	0.0013	0.00243	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—uterine cancer	0.0013	0.00242	CcSEcCtD
Scopolamine—Hyperhidrosis—Etoposide—uterine cancer	0.0013	0.00242	CcSEcCtD
Scopolamine—Hypotension—Etoposide—uterine cancer	0.00126	0.00234	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—uterine cancer	0.00125	0.00233	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—uterine cancer	0.00124	0.00231	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—uterine cancer	0.00123	0.00228	CcSEcCtD
Scopolamine—Somnolence—Etoposide—uterine cancer	0.00119	0.00222	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—uterine cancer	0.00118	0.0022	CcSEcCtD
Scopolamine—Vomiting—Dactinomycin—uterine cancer	0.00118	0.0022	CcSEcCtD
Scopolamine—Rash—Dactinomycin—uterine cancer	0.00117	0.00218	CcSEcCtD
Scopolamine—Fatigue—Etoposide—uterine cancer	0.00116	0.00216	CcSEcCtD
Scopolamine—Constipation—Etoposide—uterine cancer	0.00115	0.00214	CcSEcCtD
Scopolamine—Pain—Etoposide—uterine cancer	0.00115	0.00214	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—uterine cancer	0.00115	0.00214	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—uterine cancer	0.00115	0.00213	CcSEcCtD
Scopolamine—Sweating—Epirubicin—uterine cancer	0.00113	0.00211	CcSEcCtD
Scopolamine—Feeling abnormal—Etoposide—uterine cancer	0.00111	0.00206	CcSEcCtD
Scopolamine—Nausea—Dactinomycin—uterine cancer	0.0011	0.00205	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—uterine cancer	0.00109	0.00204	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—uterine cancer	0.00108	0.00201	CcSEcCtD
Scopolamine—Abdominal pain—Etoposide—uterine cancer	0.00106	0.00198	CcSEcCtD
Scopolamine—Body temperature increased—Etoposide—uterine cancer	0.00106	0.00198	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—uterine cancer	0.00106	0.00198	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—uterine cancer	0.00105	0.00196	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—uterine cancer	0.00105	0.00195	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—uterine cancer	0.00105	0.00195	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—uterine cancer	0.00104	0.00194	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—uterine cancer	0.00102	0.0019	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—uterine cancer	0.000998	0.00186	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—uterine cancer	0.00099	0.00185	CcSEcCtD
Scopolamine—Flushing—Epirubicin—uterine cancer	0.000984	0.00183	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—uterine cancer	0.000973	0.00181	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000968	0.0018	CcSEcCtD
Scopolamine—Asthenia—Etoposide—uterine cancer	0.000964	0.0018	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—uterine cancer	0.000961	0.00179	CcSEcCtD
Scopolamine—Pruritus—Etoposide—uterine cancer	0.00095	0.00177	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—uterine cancer	0.000947	0.00176	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—uterine cancer	0.000945	0.00176	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—uterine cancer	0.000929	0.00173	CcSEcCtD
Scopolamine—Erythema—Epirubicin—uterine cancer	0.000923	0.00172	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—uterine cancer	0.000916	0.00171	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—uterine cancer	0.00091	0.0017	CcSEcCtD
Scopolamine—ABCB1—lymph node—uterine cancer	0.000895	0.00473	CbGeAlD
Scopolamine—Dizziness—Etoposide—uterine cancer	0.000888	0.00165	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—uterine cancer	0.000876	0.00163	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—uterine cancer	0.00087	0.00162	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—uterine cancer	0.000859	0.0016	CcSEcCtD
Scopolamine—Vomiting—Etoposide—uterine cancer	0.000854	0.00159	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—uterine cancer	0.000854	0.00159	CcSEcCtD
Scopolamine—Agitation—Epirubicin—uterine cancer	0.000848	0.00158	CcSEcCtD
Scopolamine—Rash—Etoposide—uterine cancer	0.000847	0.00158	CcSEcCtD
Scopolamine—Dermatitis—Etoposide—uterine cancer	0.000846	0.00158	CcSEcCtD
Scopolamine—Headache—Etoposide—uterine cancer	0.000842	0.00157	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—uterine cancer	0.000829	0.00154	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—uterine cancer	0.000805	0.0015	CcSEcCtD
Scopolamine—Nausea—Etoposide—uterine cancer	0.000798	0.00149	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—uterine cancer	0.000785	0.00146	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.00078	0.00145	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—uterine cancer	0.000768	0.00143	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—uterine cancer	0.000767	0.00143	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—uterine cancer	0.000759	0.00141	CcSEcCtD
Scopolamine—Oedema—Epirubicin—uterine cancer	0.000753	0.0014	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—uterine cancer	0.000738	0.00138	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—uterine cancer	0.000735	0.00137	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—uterine cancer	0.000731	0.00136	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—uterine cancer	0.000728	0.00136	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000722	0.00134	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—uterine cancer	0.000711	0.00132	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—uterine cancer	0.000704	0.00131	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—uterine cancer	0.000703	0.00131	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—uterine cancer	0.000697	0.0013	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—uterine cancer	0.000683	0.00127	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—uterine cancer	0.00068	0.00127	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—uterine cancer	0.000677	0.00126	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000674	0.00125	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—uterine cancer	0.000669	0.00125	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—uterine cancer	0.000651	0.00121	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—uterine cancer	0.000649	0.00121	CcSEcCtD
Scopolamine—Pain—Epirubicin—uterine cancer	0.000644	0.0012	CcSEcCtD
Scopolamine—Constipation—Epirubicin—uterine cancer	0.000644	0.0012	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—uterine cancer	0.000621	0.00116	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—uterine cancer	0.000619	0.00115	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—uterine cancer	0.000601	0.00112	CcSEcCtD
Scopolamine—Pain—Doxorubicin—uterine cancer	0.000596	0.00111	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—uterine cancer	0.000596	0.00111	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—uterine cancer	0.000595	0.00111	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—uterine cancer	0.000595	0.00111	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000574	0.00107	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—uterine cancer	0.000551	0.00103	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—uterine cancer	0.000551	0.00103	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—uterine cancer	0.00054	0.00101	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—uterine cancer	0.000533	0.000992	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—uterine cancer	0.0005	0.000931	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—uterine cancer	0.000498	0.000928	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—uterine cancer	0.000493	0.000918	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—uterine cancer	0.000479	0.000892	CcSEcCtD
Scopolamine—Rash—Epirubicin—uterine cancer	0.000475	0.000884	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—uterine cancer	0.000474	0.000884	CcSEcCtD
Scopolamine—Headache—Epirubicin—uterine cancer	0.000472	0.000879	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—uterine cancer	0.000461	0.000858	CcSEcCtD
Scopolamine—Nausea—Epirubicin—uterine cancer	0.000447	0.000833	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—uterine cancer	0.000443	0.000825	CcSEcCtD
Scopolamine—Rash—Doxorubicin—uterine cancer	0.000439	0.000818	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—uterine cancer	0.000439	0.000818	CcSEcCtD
Scopolamine—Headache—Doxorubicin—uterine cancer	0.000436	0.000813	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—uterine cancer	0.000414	0.000771	CcSEcCtD
